Chris Barker, an Independent Statistical Consultant, discusses the differences and biases in summaries obtained from a database called PDQ vs. CTG.
Chris Barker
Advertisement
Articles by Chris Barker
Advertisement
Latest Updated Articles
Biases in Characterization of Oncology Trials for Policy DecisionsPublished: July 31st 2019 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
How Real-World Evidence Will Change Trials Without Replacing Them
2
What 2026 Will Demand From Clinical Operations: Rethinking Efficiency, Access, and AI
3
Worldwide Clinical Trials to Acquire Catalyst Clinical Research, Expanding Oncology and FSP Capabilities
4
ACT Brief: Decentralized Innovation Faces Reality, RWE Finds Its Lane, and Clinical Ops Reset for 2026
5